Although current therapies benefit some individuals, relapse rates remain high, with most studies reporting rates exceeding 70% within one year, underscoring the necessity for more effective interventions [10, 11]
Daily options: Saxenda, Rybelsus (oral) Your clinician will determine the most appropriate option based on your lab results, medical history, and insurance coverage
But for other side effects, you will largely need to manage them independently or seek guidance from external resources
Chen XW, He ZX, Zhou ZW, Yang T, Zhang X, Yang YX, et al
Further studies are needed to investigate this hypothesis, but we suspect recent changes in medication prescribing practices and medication prices will result in large datasets allowing scientists to investigate these potential relationships. Christine Rode Schwarz, PhD, of the Steno Diabetes Center in Copenhagen, and her co-authors pointed to this case in a commentary titled, Mechanism and Context: Making Sense of Adverse Events With GLP-1-based Therapy , also published in JCEM Case Reports later that year
The FDA also warns not to take Ozempic if you have a personal or family history of multiple endocrine neoplasia syndrome type 2, medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis